Insulin aspart, recombinant Subcutaneous and Temozolomide Intravenous
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Temozolomide Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: temozolomide
Brand name: Temodar
Synonyms: Temozolomide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Tempra 1
- Insulin aspart, recombinant Subcutaneous-Tempra Quicklets
- Insulin aspart, recombinant Subcutaneous-Temsirolimus
- Insulin aspart, recombinant Subcutaneous-Temsirolimus Injection
- Insulin aspart, recombinant Subcutaneous-Temsirolimus Intravenous
- Insulin aspart, recombinant Subcutaneous-Tencon
- Temozolomide Intravenous-Insulin degludec
- Temozolomide Intravenous-Insulin Degludec (U-100) Prefilled Pens
- Temozolomide Intravenous-Insulin Degludec (U-100) Vials
- Temozolomide Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Temozolomide Intravenous-Insulin degludec and liraglutide
- Temozolomide Intravenous-Insulin degludec and liraglutide Subcutaneous